Catalog No.
DHB95505
Expression system
Mammalian Cells
Species reactivity
Human
Isotype
Interleukin 1 Receptor Accessory Protein (human) fusion protein with Immunoglobulin Fc Fragment.
Clonality
Monoclonal
Target
IL1F1, Interleukin-1 alpha, IL1A, Hematopoietin-1, IL-1 alpha, Interleukin-1 beta, IL1B, Catabolin, IL1F2, IL-1 beta
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P01583 & P01584
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
Goflikicept
Current Drug Treatment for Acute and Recurrent Pericarditis., PMID:40119189
Comparative efficacy and safety of colchicine and interleukin-1 antagonists in recurrent pericarditis: a network meta-analysis., PMID:39705019
Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study., PMID:39642282
[Long-term goflkicept therapy for patients with idiopathic recurrent pericarditis: results of the interim analysis of an ongoing open-label extension study]., PMID:39467244
Results of International, Double-Blind, Randomized, Placebo-Controlled, Phase IIa Study of Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI)., PMID:39133774
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging., PMID:39111992
Goflikicept and Related IL-1 Inhibitors in the Treatment of Recurrent Pericarditis., PMID:38709249
Paradigm Shift in Diagnosis and Targeted Therapy in Recurrent Pericarditis., PMID:37458866
Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II/III Study Results., PMID:37380301